170 related articles for article (PubMed ID: 35354251)
21. Simultaneous occurrence of posterior reversible leukoencephalopathy syndrome in two cases of childhood acute lymphoblastic leukemia induction chemotherapy.
Gupta A; Swaroop C; Rastogi R; Garg R; Bakhshi S
Pediatr Hematol Oncol; 2008 Jun; 25(4):351-8. PubMed ID: 18484481
[TBL] [Abstract][Full Text] [Related]
22. Central nervous system thrombosis in pediatric acute lymphoblastic leukemia in Turkey: A multicenter study.
Guzelkucuk Z; Karapınar DY; Gelen SA; Tokgoz H; Ozcan A; Ay Y; Bahadır A; Ozbek NY; Oren AC; Ayhan AC; Akyay A; Akıncı B; Karadas N; Unuvar A; Oren H; Fettah A; Kaya Z; Isık B; Eker İ; Karaman S; Yıldırım AT; Orhan MF; Oymak Y; Timur C; Yazici N; Simsek A; Karakurt N; Toret E; Evim MS
Pediatr Blood Cancer; 2023 Aug; 70(8):e30425. PubMed ID: 37194482
[TBL] [Abstract][Full Text] [Related]
23. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
[TBL] [Abstract][Full Text] [Related]
24. Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Land VJ; Shuster JJ; Crist WM; Ravindranath Y; Harris MB; Krance RA; Pinkel D; Pullen DJ
J Clin Oncol; 1994 Sep; 12(9):1939-45. PubMed ID: 8083715
[TBL] [Abstract][Full Text] [Related]
25. [SLCO1B1c. 521T>C gene polymorphisms are associated with high-dose methotrexate pharmacokinetics and clinical outcome of pediatric acute lymphoblastic leukemia].
Zhang H; He X; Li J; Wang Y; Wang C; Chen Y; Niu C; Gao P
Zhonghua Er Ke Za Zhi; 2014 Oct; 52(10):770-6. PubMed ID: 25537545
[TBL] [Abstract][Full Text] [Related]
26. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
27. Incidence and risk factors for Central Nervous System thrombosis in paediatric acute lymphoblastic leukaemia during intensive asparaginase treatment: a single-centre cohort study.
Duarte X; Esteves S; Neto AM; Pereira F
Br J Haematol; 2016 Jul; 174(2):280-91. PubMed ID: 27018199
[TBL] [Abstract][Full Text] [Related]
28. Genomic analysis of venous thrombosis in children with acute lymphoblastic leukemia from diverse ancestries.
Zheng Y; Yang W; Estepp J; Pei D; Cheng C; Takemoto CM; Inaba H; Jeha S; Pui CH; Relling MV; Karol SE
Haematologica; 2024 Jan; 109(1):53-59. PubMed ID: 37408475
[TBL] [Abstract][Full Text] [Related]
29. Superior sagittal sinus thrombosis complicating maintenance treatment for acute lymphoblastic leukemia.
Nicholson JC; Darmady JM; Kohler JA
Pediatr Hematol Oncol; 1996; 13(3):287-91. PubMed ID: 8735346
[TBL] [Abstract][Full Text] [Related]
30. Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.
Jabbour E; O'Brien S; Kantarjian H; Garcia-Manero G; Ferrajoli A; Ravandi F; Cabanillas M; Thomas DA
Blood; 2007 Apr; 109(8):3214-8. PubMed ID: 17209054
[TBL] [Abstract][Full Text] [Related]
31. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
[TBL] [Abstract][Full Text] [Related]
33. Clinico-radiological profile, management and follow-up of methotrexate induced neurotoxicity in children with acute lymphoblastic leukemia.
Dhariwal N; Roy Moulik N; Smriti V; Dhamne C; Chichra A; Srinivasan S; Narula G; Banavali S
Leuk Lymphoma; 2023 Dec; 64(12):1971-1980. PubMed ID: 37565568
[TBL] [Abstract][Full Text] [Related]
34. Prognosis and treatment of seizures in children with acute lymphoblastic leukemia.
Maytal J; Grossman R; Yusuf FH; Shende AC; Karayalycin G; Lanzkowsky P; Schaul N; Eviatar L
Epilepsia; 1995 Aug; 36(8):831-6. PubMed ID: 7635103
[TBL] [Abstract][Full Text] [Related]
35. No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
Nielsen SN; Toksvang LN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Appell ML; Hjalgrim LL; Schmiegelow K
Cancer Chemother Pharmacol; 2021 Aug; 88(2):271-279. PubMed ID: 33928426
[TBL] [Abstract][Full Text] [Related]
36. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
[TBL] [Abstract][Full Text] [Related]
37. Treating childhood acute lymphoblastic leukemia without cranial irradiation.
Pui CH; Campana D; Pei D; Bowman WP; Sandlund JT; Kaste SC; Ribeiro RC; Rubnitz JE; Raimondi SC; Onciu M; Coustan-Smith E; Kun LE; Jeha S; Cheng C; Howard SC; Simmons V; Bayles A; Metzger ML; Boyett JM; Leung W; Handgretinger R; Downing JR; Evans WE; Relling MV
N Engl J Med; 2009 Jun; 360(26):2730-41. PubMed ID: 19553647
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group.
Junk SV; Schaeffeler E; Zimmermann M; Möricke A; Beier R; Schütte P; Fedders B; Alten J; Hinze L; Klein N; Kulozik A; Muckenthaler MU; Koehler R; Borkhardt A; Vijayakrishnan J; Ellinghaus D; Forster M; Franke A; Wintering A; Kratz CP; Schrappe M; Schwab M; Houlston RS; Cario G; Stanulla M
J Exp Clin Cancer Res; 2023 Jan; 42(1):21. PubMed ID: 36639636
[TBL] [Abstract][Full Text] [Related]
40. Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study.
Winick NJ; Smith SD; Shuster J; Lauer S; Wharam MD; Land V; Buchanan G; Rivera G
J Clin Oncol; 1993 Feb; 11(2):271-8. PubMed ID: 8426204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
